Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation

Clinical Transplantation

Volumn 25, Issue 2, 2011, Pages 207-212

  Aguilera, Isabel ^a   Sousa, Jose M ^a   Praena, Juan M ^a   Gómez Bravo, Miguel A ^a   Núñez Roldan, Antonio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Alloimmune response; Anti GSTT1 antibodies; de novo IH; GSTT1; GSTT1 mismatch; Immunosuppression

Indexed keywords

ANTIBODY; AZATHIOPRINE; CYCLOSPORIN A; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE TRANSFERASE T1 ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; DRUG CHOICE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GENOTYPE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

EID: 79953301146     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01221.x     Document Type: Article

References (9)

1. Kerkar N, Hadzic N, Davis E et al. De novo autoimmune hepatitis after liver transplantation. Lancet 1998: 351: 409.
2. Aguilera I, Sousa JM, Gavilan F, Bernardos A, Wichmann I, Nuñez-Roldan A. Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl 2004: 10: 1166.
3. Rodriguez-Mahou M, Salcedo M, Fernandez-Cruz E et al. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with GSTT1 null genotype as prognostic marker: long-term follow-up after liver transplantation. Transplantation 2007: 83: 1126.
4. Mieli-Vergani G, Vergani D. De novo autoimmune hepatitis after liver transplantation. J Hepatol 2004: 40: 3.
5. Wiesner RH, Steffen BJ, David KM, Chu AH, Gordon RD, Lake JR. Mycophenolate mofetil use is associated with decreased risk of late acute rejection in adult liver transplant recipients. Am J Transplant 2006: 6: 1609.
6. McAlister VC, Haddad E, Renouf E, Malthaner RA, Kjaer MS, Gluud LL. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transplant 2006: 6: 1578.
7. Sze YK, Dhawan A, Taylor RM et al. Pediatric liver transplantation for metabolic liver disease: experience at King's College Hospital. Transplantation 2009: 87: 87.
8. Venick RS, McDiarmid SV, Farmer DG et al. Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis. Am J Transplant 2007: 7: 955.
9. Salcedo M, Rodriguez-Mahou M, Rodriguez-Sainz C et al. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation. Liver Transpl 2009: 15: 530.